DIABETIC KETOACIDOSIS TREATMENT MARKET ANALYSIS

Market News

Key Developments-

1. In August 2020, Eli Lilly and Company (United States) added two non-branded insulin products Humalog mix 75/25 kwikpen and Humalog Junior kwikpen at a cost effective range to make treatment of type-1 diabetes and its complications such as diabetes ketoacidosis more affordable.
2. In 2019, Medtronic, a medical device company in Ireland, merged with Nova Nordisk, a pharmaceutical company in Denmark. The aim of this partnership is to develop solutions for diabetes and diabetic ketoacidosis by combining insulin dosage data from future Novo Nordisk and smart insulin pens by Medtronic’s Continuous Glucose Monitoring (CGM) devices.